Clinical Trial

tACS for Working Memory in Schizophrenia

Recruiting
View on ClinicalTrials.gov →
Summary
This study is a randomized, single-blind, sham-controlled crossover trial enrolling 30 schizophrenia patients, each receiving one active and one sham tACS session (7-day washout), targeting P3/P4 at individual alpha frequency (2mA, 30min) during a working memory task, with accuracy and reaction time as primary outcomes, alongside EEG and neurophysiological measures, to test the efficacy and mechanisms of individualized alpha-tACS on working memory.
Trial Details
NCT Number NCT07701343
Lead Sponsor Central South University
Conditions Schizophrenia, Working Memory
Enrollment 30 participants
Start Date 2026-07-06
Primary Completion 2026-10-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-14